{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:03:10Z","timestamp":1785308590307,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","jenonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Emergency Nursing"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jen.2025.11.007","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:18:39Z","timestamp":1768393119000},"page":"313-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decreasing Door-to-Analgesia Time: Increasing Use of Sickle Cell Pain Management Pathway"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1242-5480","authenticated-orcid":false,"given":"Britney","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti","family":"Ludwig-Beymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Houchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jen.2025.11.007_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pedhc.2023.10.013","article-title":"The Inequality of pain control in patients with pain from Sickle Cell disease: a case report","volume":"38","author":"Cofield","year":"2024","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.jen.2025.11.007_bib2","series-title":"Sickle cell disease","year":"2023"},{"issue":"1","key":"10.1016\/j.jen.2025.11.007_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"38","key":"10.1016\/j.jen.2025.11.007_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035237","article-title":"Understanding sickle cell disease: causes, symptoms, and treatment options","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jen.2025.11.007_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12887-023-04203-x","article-title":"Intranasal analgesia for acute moderate to severe pain in children \u2013 a systematic review and meta-analysis","volume":"23","author":"Prescott","year":"2023","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.jen.2025.11.007_bib6","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1097\/NCC.0000000000000750","article-title":"Reflections of healthcare experiences of African Americans with sickle cell disease or cancer: a qualitative study","volume":"44","author":"Dyal","year":"2021","journal-title":"Cancer Nurs"},{"issue":"6","key":"10.1016\/j.jen.2025.11.007_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/j.pain.0000000000002528","article-title":"Mechanisms of injustice: what we (do not) know about racialized disparities in pain","volume":"163","author":"Mathur","year":"2022","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jen.2025.11.007_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.NURSE.0000820064.60540.ff","article-title":"Addressing healthcare bias in caring for patients with sickle cell disease","volume":"52","author":"Marr","year":"2025","journal-title":"Nursing"},{"issue":"12","key":"10.1016\/j.jen.2025.11.007_bib9","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jen.2025.11.007_bib10","series-title":"Evidence-Based Management of Sickle Cell Disease","year":"2014"},{"issue":"3","key":"10.1016\/j.jen.2025.11.007_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/15360288.2022.2084209","article-title":"Evaluation of guideline-recommended pain management in acute sickle cell crisis and its effect on patient outcomes","volume":"36","author":"Seaser","year":"2022","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"10.1016\/j.jen.2025.11.007_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ejh.13924","article-title":"Time to pain relief: a randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease","volume":"110","author":"Tanabe","year":"2023","journal-title":"Eur J Haematol"},{"issue":"7","key":"10.1016\/j.jen.2025.11.007_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/JXX.0000000000000885","article-title":"Using an individualized pain management plan for African American adults with sickle cell disease","volume":"35","author":"Macey-Stewart","year":"2023","journal-title":"J Am Assoc Nurse Pract"},{"issue":"4","key":"10.1016\/j.jen.2025.11.007_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajh.26837","article-title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: a multicenter pediatric emergency medicine perspective","volume":"98","author":"Rees","year":"2023","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jen.2025.11.007_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.jen.2025.11.007_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/pch\/pxz022","article-title":"Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department","volume":"25","author":"Paquin","year":"2020","journal-title":"Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.jen.2025.11.007_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pbc.24864","article-title":"Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease","volume":"61","author":"Ender","year":"2014","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Emergency Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099176725004623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099176725004623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:52:56Z","timestamp":1772873576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0099176725004623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0099176725004623"],"URL":"https:\/\/doi.org\/10.1016\/j.jen.2025.11.007","relation":{},"ISSN":["0099-1767"],"issn-type":[{"value":"0099-1767","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreasing Door-to-Analgesia Time: Increasing Use of Sickle Cell Pain Management Pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Emergency Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jen.2025.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Emergency Nurses Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}